特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界のポイントオブケア(POC)分子診断市場:成長、動向、および予測

Point-of-Care Molecular Diagnostics Market - Growth, Trends, and Forecasts (2020 - 2025)

発行 Mordor Intelligence LLP 商品コード 922063
出版日 ページ情報 英文 110 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=106.61円で換算しております。
世界のポイントオブケア(POC)分子診断市場:成長、動向、および予測 Point-of-Care Molecular Diagnostics Market - Growth, Trends, and Forecasts (2020 - 2025)
出版日: 2020年06月01日 ページ情報: 英文 110 Pages
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
概要

当レポートは世界のポイントオブケア(POC)分子診断市場について調査しており、市場機会や動向、成長および阻害要因、用途・技術・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 市場成長要因
    • 感染症と癌の増加する有病率
    • ポイントオブケア診断の需要の高まり
    • 技術とゲノム薬理学(ファーマコゲノミクス)の最近の進歩
  • 市場阻害要因
    • 不確実な償還シナリオ
    • 複雑性の高い検査施設の必要性
  • ポーターのファイブフォース分析

第5章 市場セグメンテーション

  • 用途別
    • 感染症
    • 腫瘍学
    • 血液学
    • 出生前検査
    • 内分泌学
    • その他の用途
  • 技術別
    • PCR
    • 遺伝子配列
    • ハイブリダイゼーション
    • マイクロアレイ
  • エンドユーザー別
    • 病院
    • ホームケア
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Abbott Laboratories
    • Bayer Healthcare
    • F. Hoffmann-La Roche Ltd.
    • Bio-Rad Laboratories
    • Danaher Corporation
    • BioMerieux
    • Dako
    • Abaxis Inc.
    • OraSure Technologies Inc.
    • Qiagen

第7章 市場機会および今後の動向

目次
Product Code: 67594

Point-of-Care (POC) Molecular testing enables physicians to improve the standard of care by combining quick diagnosis with treatment decision in the first visit by the patient instead of hours and days to have the test results. This would help prescribe treatment in the first instance without having to wait for final results. In past decades, the prevalence of infectious diseases and chronic illnesses like cancer have increased. This has led to an increase in demand for novel diagnostic methods, which has led to progress in technological advancements and pharmacogenomics. This has also increased the demand for POC testing. These factors have helped the growth of the POC molecular testing market.

However, uncertain reimbursement scenarios have dissuaded many manufacturers to enter the market. Also, lack of high-complexity test centers to use POC molecular testing have also hindered the market growth.

Key Market Trends

Application in Oncology is Expected to Register a High CAGR

Cancer Research UK suggests that the population suffering from cancer is expected to increase in the future. As per the report, if recent trends in the incidence of major cancers and population growth are consistent, it is predicted there will be 27.5 million new cancer cases worldwide each year by 2040. This is an increase of 61.7% from 17 million new cancer cases worldwide in 2018.

Many current point-of-care (POC) diagnostics utilize lateral flow immunoassay based technologies. Lateral flow immunoassays are devices that incorporate antibodies to detect the presence of an analyte like cancer biomarkers. In principle, a lateral flow test is a device that will provide a qualitative answer to the presence of a biomarker in a short period of time. Hence, the demand for these quick detection tests is expected to increase as the incidence of cancer increases.

North America is Expected to Dominate the Market

The prevalence of cancer in the United States is one of the highest in North American countries like the United States (US) and Mexico. According to a 2018 report by the National Cancer Institute, the incidence of cancer in the US is 439.2 per 100,000 men and women per year. The prevalence of infectious disease is also high in the United States and Mexico. This has created a high demand for point-of-care diagnostics tests.

However, the United States has a developed and well-structured health care system. The system also encourages research and development. These policies encourage global players to enter the US, and eventually the North American market. As a result, this region enjoys the presence of many global market players. As high demand is met by the presence of global players in the region, the market is further expected to increase.

Competitive Landscape

The majority of the point of care molecular diagnostic tests are being developed by the global key players. Market leaders with more funds for research and a better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing the emergence of some small players due to the rise of awareness. This has also helped the market to grow.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Infectious Diseases and Cancer
    • 4.2.2 Rising Demand for Point-of-care Diagnostics
    • 4.2.3 Recent Advancements in Technology and Pharmacogenomics
  • 4.3 Market Restraints
    • 4.3.1 Uncertain Reimbursement Scenario
    • 4.3.2 Need for High-complexity Testing Centers
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Application
    • 5.1.1 Infectious Diseases
    • 5.1.2 Oncology
    • 5.1.3 Hematology
    • 5.1.4 Prenatal Testing
    • 5.1.5 Endocrinology
    • 5.1.6 Other Applications
  • 5.2 By Technology
    • 5.2.1 PCR
    • 5.2.2 Genetic Sequencing
    • 5.2.3 Hybridization
    • 5.2.4 Microarray
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Homecare
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Bayer AG
    • 6.1.3 F. Hoffmann-La Roche Ltd
    • 6.1.4 Bio-Rad Laboratories
    • 6.1.5 Danaher Corporation
    • 6.1.6 BioMerieux
    • 6.1.7 Agilent Technologies
    • 6.1.8 OraSure Technologies Inc.
    • 6.1.9 Thermo Fisher Scientific (Qiagen NV)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS